Comparison of olanzapine, quetiapine, and risperidone in first-episode psychosis: A randomized 52-week trial

被引：0
作者：
McEvoy, JP
Lieberman, JA
Perkins, D
Hamer, RM
机构：
[1] John Umstead Hosp, Butner, NC 27509 USA
[2] Duke Univ, Med Ctr, Durham, NC USA
[3] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY USA
[4] Univ N Carolina, Sch Med, Dept Psychiat, Chapel Hill, NC USA
来源：
SCHIZOPHRENIA RESEARCH | 2006年 / 81卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：22 / 22
页数：1
相关论文
共 50 条
  • [21] Multisite prediction of 4-week and 52-week treatment outcomes in patients with first-episode psychosis: a machine learning approach
    Koutsouleris, Nikolaos
    Kahn, Rene S.
    Chekroud, Adam M.
    Leucht, Stefan
    Falkai, Peter
    Wobrock, Thomas
    Derks, Eske M.
    Fleischhacker, Wolfgang W.
    Hasan, Alkomiet
    LANCET PSYCHIATRY, 2016, 3 (10): : 935 - 946
  • [22] Neurocognitive Effectiveness of Haloperidol, Risperidone, and Olanzapine in First-Episode Psychosis: A Randomized, Controlled 1-Year Follow-Up Comparison
    Crespo-Facorro, Benedicto
    Rodriguez-Sanchez, Jose M.
    Perez-Iglesias, Rocio
    Mata, Ignacio
    Ayesa, Rosa
    Ramirez-Bonilla, MariLuz
    Martinez-Garcia, Obdulia
    Vasquez-Barquero, Jose L.
    JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (05) : 717 - 729
  • [23] Randomized comparison of olanzapine versus risperidone for the treatment of first-episode schizophrenia: 4-Month outcomes
    Robinson, Delbert G.
    Woerner, Margaret G.
    Napolitano, Barbara
    Patel, Raman C.
    Sevy, Serge M.
    Gunduz-Bruce, Handan
    Soto-Perello, Jose M.
    Mendelowitz, Alan
    Khadivi, Ali
    Miller, Rachel
    McCormack, Joanne
    Lorell, Beth S.
    Lesser, Martin L.
    Schooler, Nina R.
    Kane, John M.
    AMERICAN JOURNAL OF PSYCHIATRY, 2006, 163 (12) : 2096 - 2102
  • [24] Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia:: A 52-week randomized trial of clozapine vs chlorpromazine
    Lieberman, JA
    Phillips, M
    Gu, HB
    Stroup, S
    Zhang, PY
    Kong, L
    Ji, ZF
    Koch, G
    Hamer, RM
    NEUROPSYCHOPHARMACOLOGY, 2003, 28 (05) : 995 - 1003
  • [25] Atypical and Conventional Antipsychotic Drugs in Treatment-Naive First-Episode Schizophrenia: A 52-Week Randomized Trial of Clozapine Vs Chlorpromazine
    Jeffrey A Lieberman
    Michael Phillips
    Hongbin Gu
    Scott Stroup
    Peiyan Zhang
    Lan Kong
    Zhongfu Ji
    Gary Koch
    Robert M Hamer
    Neuropsychopharmacology, 2003, 28 : 995 - 1003
  • [26] Open-label randomized trial comparing the efficacy and tolerability of quetiapine and olanzapine in first episode psychosis in adolescents
    Parellada, M. J.
    Moreno, D.
    Ruiz-Sancho, A.
    Medina, O.
    Arango, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S377 - S378
  • [27] Esquire Trial Efficacy and Adverse Effects of Quetiapine Versus Risperidone in First-Episode Schizophrenia
    Gafoor, Rafael
    Landau, Sabine
    Craig, Tom K. J.
    Elanjithara, Thomas
    Power, Paddy
    McGuire, Philip
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2010, 30 (05) : 600 - 606
  • [28] Olanzapine in subjects with a first-episode psychosis non-responsive, intolerant or non-compliant to a first-line trial of risperidone
    Lambert, M
    Conus, P
    Naber, D
    McGorry, PD
    Schimmelmann, BG
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2005, 9 (04) : 244 - 250
  • [29] Cognitive Efficacy of Quetiapine in Early-Onset First-Episode Psychosis: A 12-Week Open Label Trial
    Sébastien Urben
    Pierre Baumann
    Sandra Barcellona
    Muriel Hafil
    Ulrich Preuss
    Claire Peter-Favre
    Stéphanie Clarke
    Olivier Halfon
    Laurent Holzer
    Psychiatric Quarterly, 2012, 83 : 311 - 324
  • [30] Cognitive Efficacy of Quetiapine in Early-Onset First-Episode Psychosis: A 12-Week Open Label Trial
    Urben, Sebastien
    Baumann, Pierre
    Barcellona, Sandra
    Hafil, Muriel
    Preuss, Ulrich
    Peter-Favre, Claire
    Clarke, Stephanie
    Halfon, Olivier
    Holzer, Laurent
    PSYCHIATRIC QUARTERLY, 2012, 83 (03) : 311 - 324
12345